Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing interferon alfa-2a (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Interferon-A-2a adverse reaction (disorder) |
Causative agent (attribute) |
True |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to interferon alfa-2a |
Causative agent (attribute) |
False |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 18million iu/1mL injection solution (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 6million iu/mL injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 4.5million iu/0.5mL prefilled syringe (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 12million iu/mL injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 9million iu/0.5mL prefilled syringe (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 18million iu/0.6mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 6miu/vial injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 9miu/vial injection solution 0.9mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 36000000iu/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 3miu/vial injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 18000000iu/3mL injection solution 3mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 3miu/vial injection solution 0.5mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 6miu/vial injection solution 0.5mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 18million iu/0.5mL injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2a (substance) |
Is a |
False |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to interferon alfa-2a |
Causative agent (attribute) |
True |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing interferon alfa-2a in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Interferon alfa-2a only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only interferon alfa-2a in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Peginterferon alfa-2a (substance) |
Is modification of (attribute) |
True |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely interferon alfa-2a (as peginterferon alfa-2a) 270 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Interferon alfa-2a (as peginterferon alfa-2a) 360 microgram/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Interferon alfa-2a (as peginterferon alfa-2a) 180 microgram/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Interferon alpha-2a preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |